Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Degenerative Brain Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03845439
What this trial is testing

Estimate of the TSD Based on the Quantification of the Tau Protein in CSF

Who this might be right for
Time of Death
University Hospital, Montpellier 80
Not applicableLooking for participantsNCT05943002
What this trial is testing

Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia

Who this might be right for
Friedreich Ataxia
German Center for Neurodegenerative Diseases (DZNE) 200
Not applicableLooking for participantsNCT07360977
What this trial is testing

Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)

Who this might be right for
PARKINSON DISEASE (Disorder)Multiple Sclerosis (MS) - Relapsing-remittingPediatric Patients Affected by Neuromuscolar and Degenerative Diseases
IRCCS Centro Neurolesi Bonino Pulejo 300
Early research (Phase 1)Ended earlyNCT05160558
What this trial is testing

A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3

Who this might be right for
Spinocerebellar Ataxia Type 3
Biogen 8
Large-scale testing (Phase 3)Active Not RecruitingNCT05515536
What this trial is testing

Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia

Who this might be right for
Friedreich Ataxia
PTC Therapeutics 130
Testing effectiveness (Phase 2)Study completedNCT01937013
What this trial is testing

Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia

Who this might be right for
Frontotemporal Dementia
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 52
Testing effectiveness (Phase 2)Looking for participantsNCT07304024
What this trial is testing

A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

Who this might be right for
Central Auditory Processing DisorderHearing Impaired (Partially)Hearing+23 more
University of Colorado, Denver 344
Not applicableStudy completedNCT05400278
What this trial is testing

Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome

Who this might be right for
Bardet-Biedl Syndrome
Oslo University Hospital 30
Testing effectiveness (Phase 2)UnknownNCT03260920
What this trial is testing

Intranasal Oxytocin for Frontotemporal Dementia

Who this might be right for
Frontotemporal Dementia
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 112
Not applicableUnknownNCT05923307
What this trial is testing

Multifactorial Approach to Dementia, Multicentric Study

Who this might be right for
Dementia of Alzheimer TypeDementia FrontotemporalNarcissistic Personality Disorder+2 more
Daniel Serrani Azcurra 450
Testing effectiveness (Phase 2)Study completedNCT02656498
What this trial is testing

[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentNeurodegenerative Diseases
Jae Seung Kim 135
Not applicableActive Not RecruitingNCT04529252
What this trial is testing

Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases

Who this might be right for
Spinocerebellar AtaxiasCerebellar AtaxiaNucleotide Repeat Disease
Mayo Clinic 1,000
Not applicableUnknownNCT05317871
What this trial is testing

Clearance Mechanisms in Atypical Neurodegenerative Diseases

Who this might be right for
Neurodegenerative DiseasesFrontotemporal Degeneration
Ludwig-Maximilians - University of Munich 80
Not applicableStudy completedNCT00355498
What this trial is testing

Amyloid Plaque and Tangle Imaging in Aging and Dementia

Who this might be right for
Memory DisordersAlzheimer's Disease
University of California, Los Angeles 170
Early research (Phase 1)WithdrawnNCT06483802
What this trial is testing

ASP2016 in Adults Who Have Heart Disease Associated With Friedreich Ataxia

Who this might be right for
Friedreich AtaxiaCardiomyopathy
Astellas Gene Therapies
Testing effectiveness (Phase 2)Study completedNCT01339884
What this trial is testing

Resveratrol as Treatment for Friedreich Ataxia

Who this might be right for
Friedreich Ataxia
Murdoch Childrens Research Institute 27
Not applicableStudy completedNCT02050464
What this trial is testing

Computational Tools for Early Diagnosis of Memory Disorders

Who this might be right for
Alzheimer DiseaseFrontotemporal DementiaDementia, Vascular+1 more
University of Eastern Finland 126
Not applicableWithdrawnNCT05830214
What this trial is testing

Digital Smartwatch Measurements as Potential Biomarkers for Remote Disease Tracking in ALS

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisMuscular Atrophy, Progressive+2 more
University of Alberta
Not applicableStudy completedNCT05787704
What this trial is testing

Walking and Thinking - Brain Activity During Complex Walking in People With Multiple Sclerosis

Who this might be right for
Multiple SclerosisGait Disorders, NeurologicNeuro-Degenerative Disease+1 more
Karolinska Institutet 41
Large-scale testing (Phase 3)Ended earlyNCT04378075
What this trial is testing

Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Who this might be right for
Mitochondrial DiseasesDrug Resistant EpilepsyLeigh Disease+5 more
PTC Therapeutics 68
Next Page